Myositis ossificans progressiva, unspecified site
ICD-10 M61.10 is a billable code used to indicate a diagnosis of myositis ossificans progressiva, unspecified site.
Myositis ossificans progressiva (MOP) is a rare genetic disorder characterized by the abnormal formation of bone in muscles, tendons, and other connective tissues. This condition is caused by mutations in the ACVR1 gene, which plays a crucial role in the regulation of bone growth and development. Patients with MOP typically experience progressive muscle stiffness and weakness, often beginning in childhood or early adulthood. The hallmark of this condition is the formation of heterotopic ossification, where bone tissue forms in areas where it should not, leading to significant mobility issues and pain. The condition can be triggered by trauma or injury, but it can also occur spontaneously. Diagnosis is primarily clinical, supported by imaging studies such as X-rays or MRIs that reveal abnormal bone growth. Management focuses on symptomatic relief, physical therapy, and avoiding activities that may exacerbate the condition. Surgical intervention is generally avoided due to the risk of further ossification. As the condition progresses, patients may face severe limitations in their range of motion and overall quality of life.
Detailed clinical notes on muscle strength, range of motion, and any imaging studies performed.
Patients presenting with unexplained muscle stiffness and pain, particularly after trauma.
Documentation should emphasize the progressive nature of the condition and any genetic testing results.
Genetic testing results and family history of similar conditions.
Patients with a family history of myositis ossificans or unexplained ossification.
Ensure that genetic counseling notes are included in the medical record.
Used for follow-up visits for management of myositis ossificans progressiva.
Detailed notes on patient history, examination findings, and treatment plans.
Rheumatology or genetics specialists should document their assessments thoroughly.
Myositis ossificans progressiva is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues, leading to progressive stiffness and weakness.
Diagnosis is based on clinical presentation, family history, imaging studies, and genetic testing for ACVR1 mutations.
